To determine whether amniotic fluid (AF) CXCL10 concentration is associated with histologic chronic chorioamnionitis in patients with preterm labor (PTL) and preterm prelabor rupture of the membranes (PROM).
| INTRODUCTION
Preterm labor is a syndrome characterized by the combination of increased uterine contractility, cervical remodeling (ie, ripening and dilatation), and decidual membrane activation, caused by multiple pathologic processes. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] One of the mechanisms of disease implicated in preterm parturition is a breakdown of immune tolerance, which may evolve into maternal anti-fetal rejection.
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The fetus and placenta express both maternal and paternal antigens; therefore, they are semiallografts. [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] The placenta is considered to be the most successful transplant in nature, a biological adaptation accomplished by immune tolerance. [43] [44] [45] [46] [47] [48] Tolerance is a specific immunological term that refers to "the active state of antigenspecific non-responsiveness" 49 leading to diminished reactivity to paternal antigens expressed by the placenta and/or fetus; it is considered key for successful pregnancy. 31, 33, 39, 40, [50] [51] [52] [53] The mechanisms responsible for tolerance in pregnancy include the following: (i) T-cell chemokine gene silencing in the decidual cells; 54 (ii) a suppressive role of regulatory T cells; 52, [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] (iii) expression of non-classical major histocompatibility complex molecules on trophoblast cells that do not elicit a maternal immune response; [65] [66] [67] [68] [69] [70] (iv) changes in tryptophan catabolisms; [71] [72] [73] [74] [75] (v) T-cell apoptosis; 76, 77 (vi) complement; 78-90 and (vii) costimulatory molecules such as the programmed death ligand. [91] [92] [93] Other mechanisms for tolerance are not currently understood. The interested reader is referred to recent contributions by Sing Sing Way's laboratory 28, 39, [94] [95] [96] and Adrian Erlebacher.
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In transplantation medicine, failure of tolerance is responsible for graft rejection characterized by an infiltration of the recipient's CD8+ (cytotoxic) T cells into the graft and an overexpression of C-X-C motif chemokine 10 (CXCL10), a marker of allograft rejection.
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In obstetrics, rejection as a mechanism of disease has been largely overlooked. However, recent evidence suggests that maternal antifetal rejection is operative in a subset of patients with spontaneous preterm labor, 15, 16, 20, 26, 103 preterm prelabor rupture of the membranes (PROM), 20 fetal death, 17, 25 recurrent abortion, 19 and other obstetrical syndromes. 14, 18, [21] [22] [23] [24] 103 Maternal lymphocytes (akin to a transplant recipient) can infiltrate the chorioamniotic membranes (fetal tissue or semiallograft), lead to chronic chorioamnionitis, 15, 26 and induce trophoblast apoptosis, which, when excessive, can result in graft failure (eg, membrane rupture or activation of the decidual membrane and the initiation of labor). 15, 104 The chemotactic signal inducing the migration of maternal T lymphocytes into the chorioamniotic membranes appears to be present in the amniotic cavity. One such chemokine is CXCL10, 15, 104, 105 and an increased concentration of this chemokine in the amniotic fluid has been characterized by our group to represent a distinct form of intra-amniotic inflammation, which is associated with chronic inflammatory lesions of the placenta and a novel form of fetal inflammatory response syndrome (FIRS) or FIRS type 2.
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This distinct form of intra-amniotic inflammation differs from the intra-amniotic inflammatory process observed in patients with preterm labor due to microbial invasion of the amniotic cavity (MIAC).
Microorganisms and their products can induce a robust intra-amniotic inflammatory response characterized by an elevation in amniotic fluid The histologic hallmark of MIAC is acute histologic chorioamnionitis, defined by the infiltration of maternal neutrophils into the chorioamniotic membranes. 109, [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] Related lesions are chorionic vasculitis 197 and the spectrum of lesions observed in cases of funisitis. 155, 196, [198] [199] [200] [201] [202] [203] [204] Therefore, at this time, at least two major types of intra-amniotic inflammation appear to occur in the context of spontaneous preterm laborone associated with MIAC or induced by danger signals 124, [205] [206] [207] [208] [209] and the other associated with chronic inflammatory lesions of the placenta (often attributed to maternal anti-fetal rejection).
The concentration of the T-cell chemokine CXCL10 (IP-10) is considered a marker for chronic inflammatory lesions associated with allograft rejection and chronic chorioamnionitis in the case of pregnancy. In contrast, IL-6, IL-8, IL-1, and TNF-α are examples of cytokines involved in acute inflammatory lesions of the placenta. 109, 128, 130, 196, 210 The objective of this study was to determine the prevalence and clinical significance of an elevated CXCL10 concentration in the amniotic fluid of patients with a diagnosis of either preterm labor with intact membranes or preterm PROM and whether an elevation in CXCL10 concentration is associated with chronic chorioamnionitis, as an increased concentration of IL-6 and CXCL10 is frequently observed in patients with intra-amniotic infection and acute histologic chorioamnionitis.
| MATERIALS AND METHODS

| Study population
A nested retrospective cohort study was conducted by searching the at 1300 g for 10 minutes at 4°C shortly after collection and stored at −70°C until analysis. Concentrations of IL-6 and CXCL10 in the amniotic fluid (ng/mL) were determined by the enzyme-linked immunosorbent assay test, using immunoassays obtained from R&D Systems (Minneapolis, MN, USA). The assay time, volume, and other characteristics for each method have been previously described. 15, 123, 124, 169, [205] [206] [207] 
| Clinical definitions
Gestational age was determined by the last menstrual period and confirmed by ultrasound examination, or by ultrasound examination alone if the sonographic determination of gestational age was not consistent with menstrual dating. 211 Preterm labor was diagnosed by the presence of at least two regular uterine contractions every 10 minutes in association with cervical changes in patients with a gestational age between 20 and 36 6/7 weeks that led to preterm delivery (defined as birth prior to the 37th week of gestation). Preterm PROM was diag- The diagnosis of acute histologic chorioamnionitis was based on the presence of acute inflammatory changes in the extraplacental chorioamniotic membrane roll and/or chorionic plate of the placenta, using the criteria previously described. [188] [189] [190] 192, 196, 216, 217 The grading and staging of placental lesions consistent with amniotic fluid infection was defined according to the Amniotic Fluid Infection Nosology Committee of the Perinatal Section of the Society for Pediatric Pathology as reported by Redline et al. 188 Acute funisitis was defined as the presence of neutrophils in the wall of the umbilical vessels and/or Wharton's jelly. 188, 196, 197 
| Study groups
Participants were allocated into four study groups, according to 
| Statistical analysis
The Kolmogorov-Smirnov test was used to assess the normality of arithmetic data distributions. The Kruskal-Wallis test and the Mann-Whitney U test were used to make comparisons among and between groups for arithmetic variables. The chi-square test or Fisher's exact test was used for comparisons of proportions. Multinomial logistic regression models were fit to examine magnitudes of association with primary and secondary outcomes, adjusting for gestational age at amniocentesis. Statistical analysis was performed using SAS 9.4 (Cary, NC, USA). Confidence intervals (95% CI) that do not include the null hypothesis (ie, an odds ratio [OR] of "1.0") are considered statistically significant.
| RESULTS
| Clinical characteristics
One hundred and sixty-eight women with either preterm labor with intact membranes (72%) or preterm PROM (28%) were included in this study. Table 1 displays the clinical characteristics of the participants;
88% were African American, 34% were nulliparous, and 83% deliv- Table 2 .
An elevation in the concentration of both amniotic fluid CXCL10 (≥2.2 ng/mL) and amniotic fluid IL-6 (≥2.6 ng/mL) was observed in 35% (59/168) of the patients, whereas 18% (30/168) had an iso- 
| Acute and chronic chorioamnionitis in relationship to amniotic fluid concentrations of CXCL10 and IL-6
The prevalence of chronic chorioamnionitis was highest in patients with an isolated elevation in amniotic fluid CXCL10 concentration (46.7%; 14/30) and was lowest in those with an isolated elevation in amniotic fluid IL-6 concentration (7.7%; 2/26) ( Table 2 ). In contrast, the prevalence of acute chorioamnionitis ≥stage 2 was highest in patients with an isolated elevation in both amniotic fluid IL-6 and CXCL10 concentrations (52.5%; 31/59), followed by patients with an isolated elevation in amniotic fluid IL-6 concentration (42.3%; 11/26).
The prevalence of such placental lesions was observed in 13% (4/30) of patients with an isolated elevation in amniotic fluid CXCL10 concentration. Interestingly, almost all patients with acute and chronic chorioamnionitis (83.3%; 5/6) had an elevation in both amniotic fluid IL-6 and CXCL10 concentrations ( Table 2 ).
The magnitudes of association between the study groups according to amniotic fluid CXCL10 and IL-6 concentrations and the presence or absence of acute or chronic chorioamnionitis are described in concentration of AF CXCL10 (ng/mL) was 1.6 (0.9-3.4), 3.1 (1.1-6.9), 4.1 (1.9-7.7), and 3.9 (3.0-9.7) in patients with neither acute chorioamnionitis nor chronic chorioamnionitis, acute chorioamnionitis (≥stage 2), chronic chorioamnionitis, and acute and chronic chorioamnionitis, respectively. AF, amniotic fluid; CXCL, C-X-C motif chemokine; acute chorioamnionitis, the presence of acute chorioamnionitis ≥stage 2 in the absence of chronic chorioamnionitis; chronic chorioamnionitis, the presence of chronic chorioamnionitis in the absence of acute chorioamnionitis ≥stage 2 
| Two types of intra-amniotic inflammation in preterm labor
| Microbial-associated and sterile intraamniotic inflammation
Preterm parturition is a syndrome caused by multiple etiologies. 2, 4, [6] [7] [8] 12 Intra-amniotic infection is present in one of every three preterm deliveries and is even more frequent in cases of spontaneous preterm labor with intact membranes. [221] [222] [223] [224] [225] [226] Microorganisms are detected in the amniotic cavity in 25-40% of patients with preterm labor and intact membranes who deliver preterm 133, [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] and in 50-75% of those with preterm PROM at the time of labor onset.
235
The earlier the gestational age at presentation, the greater the risk of MIAC or intra-amniotic infection. GA at delivery (wk) AF, amniotic fluid; CXCL, C-X-C motif chemokine; GA, gestational age; IL, interleukin; acute chorioamnionitis, the presence of acute chorioamnionitis ≥stage 2 in the absence of chronic chorioamnionitis; chronic chorioamnionitis, the presence of chronic chorioamnionitis in the absence of acute chorioamnionitis ≥stage 2.
Data presented as % (n) or median (interquartile). Normal AF IL-6 and CXCL10 concentrations: IL-6 <2.6 ng/mL and CXCL10 <2.2 ng/mL; isolated increase in AF IL-6 concentrations: IL-6 ≥2.6 ng/mL; isolated increase in AF CXCL10 concentrations: CXCL10 ≥2.2 ng/mL; increase in both AF IL-6 and CXCL10 concentrations: IL-6 ≥2.6 ng/mL and CXCL10 ≥2. membranes. Among these inflammation-related proteins, IL-6 has become the key cytokine for the diagnosis of intra-amniotic inflammation because its increase in concentration has been associated with a shorter interval to delivery and an increased rate of neonatal morbidity and mortality. 109, 124, 267, 268 Recently, an in-depth analysis of the chemokine network in preterm labor with and without inflammation, sterile inflammation, and intra-amniotic infection has been reported. 269 Network analysis provides a greater level of insight into the biology of the process, given that the protein inflammatory process operates through a network rather than single molecules. 269 Collectively, amniotic fluid IL-6 is a pragmatic marker of either microbial-associated or sterile intra-amniotic inflammation. With the development of high-fidelity assays that allow multiplex analysis of biological fluids, we anticipate that it will be possible to characterize with greater detail the biology of the immune response, timetable, response to therapy, and other important clinical characteristics.
| A novel form of intra-amniotic inflammation characterized by CXCL10
We previously identified a form of intra-amniotic inflammation characterized by an increase in CXCL10 concentration 15,169 associated with chronic chorioamnionitis, the most common placental lesion in late spontaneous preterm delivery. 22 This form of intra-amniotic inflammation is considered a manifestation of maternal anti-fetal rejection, 15, 22, 26, 169 as an infectious cause has not been identified by the use of cultivation and molecular methods.
Compelling evidence suggests that CXCL10 plays an important role in the pathogenesis of graft failure and rejection in other organ systems. [97] [98] [99] [100] [101] [102] Overexpression of this T-cell chemokine has been observed in the serum/plasma, 270, 271 
Magnitudes of association between the study groups according to amniotic fluid IL-6 and CXCL10 concentrations and the presence or absence of acute (≥stage 2) or chronic chorioamnionitis. Results were obtained by fitting a multinomial logistic regression model and adjusting for gestational age at amniocentesis. AF, amniotic fluid; CXCL, C-X-C motif chemokine; IL, interleukin. Normal AF IL-6 and CXCL10 concentrations: IL-6 <2.6 ng/mL and CXCL10 <2.2 ng/mL; isolated increase in AF IL-6 concentration: IL-6 ≥2.6 ng/mL; isolated increase in AF CXCL10 concentration: CXCL10 ≥2.2 ng/mL; increase in both AF IL-6 and CXCL10 concentrations: IL-6 ≥2.6 ng/mL and CXCL10 ≥2.2 ng/mL. Acute chorioamnionitis: the presence of acute chorioamnionitis ≥stage 2 in the absence of chronic chorioamnionitis; chronic chorioamnionitis: the presence of chronic chorioamnionitis in the absence of acute chorioamnionitis ≥stage 2. None of the patients grouped by their normal AF IL-6 and CXCL10 concentrations had both acute and chronic placental inflammatory lesions; therefore, the computation of the odds ratios relative to the common reference cannot be performed. Red values indicate statistically significant associations between the study group on the left and the outcome named in the column header transplantation. [286] [287] [288] Moreover, there is a significant correlation between serum/plasma CXCL10 concentrations and the timing and severity of allograft rejection. 100, 270, 271, 279, 285 In chronic chorioamnionitis, which can be considered a form of allograft rejection, there is an upregulation of CXCL9, CXCL10, and CXCL11 mRNA expression in the chorioamniotic membranes. Interestingly, approximately 40% of placentas with chronic chorioamnionitis from patients with preterm labor or preterm PROM have concomitant VUE and chronic deciduitis with plasma cells. 15 We demonstrated the systemic derangement of the chemokine concentrations that occurred in the maternal and fetal circulation systems of patients with VUE, which was distinct from that observed in the setting of acute chorioamnionitis. 14 The mRNA expression of a subset of chemokines and their receptors (CXCL9, CXCL10, CXCL11, CXCL13, and CXCR3) was also higher in VUE placentas than in normal placentas. 14 Moreover, the median concentrations of CXCL9, CXCL10, and CXCL11 in maternal and fetal plasma were higher in patients with VUE than in those without this lesion. 14 Therefore, we also consider VUE as a manifestation of maternal anti-fetal rejection unless a microorganism can be identified.
In summary, intra-amniotic inflammation associated with maternal anti-fetal rejection differs from microbial-associated intra-amniotic inflammation; it is characterized by an elevation in T-cell chemokine concentration in the amniotic fluid and chorioamniotic membranes as well as the presence of chronic inflammatory lesions of the placenta.
F I G U R E 4
Magnitudes of association between the study groups on the left and the outcomes listed in the column heading at the top. Results were obtained by fitting a multinomial logistic regression model and adjusting for gestational age at amniocentesis. AF, amniotic fluid; CXCL, C-X-C motif chemokine; IL, interleukin. Normal AF IL-6 and CXCL10 concentrations: IL-6 <2.6 ng/mL and CXCL10 <2.2 ng/mL; isolated increase in AF IL-6 concentration: IL-6 ≥2.6 ng/mL; isolated increase in AF CXCL10 concentration: CXCL10 ≥2.2 ng/mL; increase in both AF IL-6 and CXCL10 concentrations: IL-6 ≥2.6 ng/mL and CXCL10 ≥2.2 ng/mL. Acute chorioamnionitis: the presence of acute chorioamnionitis ≥stage 2 in the absence of chronic chorioamnionitis; chronic chorioamnionitis: the presence of chronic chorioamnionitis in the absence of acute chorioamnionitis ≥stage 2; placental lesions associated with maternal anti-fetal rejection: chronic chorioamnionitis, villitis of unknown etiology (VUE), and chronic deciduitis with plasma cells. None of the patients grouped by their normal AF IL-6 and CXCL10 concentrations had both acute and chronic placental inflammatory lesions; therefore, the computation of the odds ratios relative to the common reference cannot be performed. Red values indicate statistically significant associations between the study group on the left and the outcome named in the column header
| CXCL10: a biomarker for chronic placental inflammatory lesions
The results of the study herein support the view that CXCL10 is a marker for chronic inflammatory lesions of the placenta. Our findings are consistent with those of Gervasi et al., 169 who reported that midtrimester amniotic fluid CXCL10 concentrations >502 pg/mL were associated with late (>32 weeks) spontaneous preterm delivery (OR:
3.9; 95% CI: 1.6-9.9), whereas elevated amniotic fluid IL-6 concentrations (>1740 pg/mL) were associated with a higher risk of spontaneous preterm delivery prior to 32 weeks of gestation (OR: 9.5; 95%
CI: 2.9-31.1). Our study differs in that we examined the relationship between the isolated elevation in either amniotic fluid CXCL10 or amniotic fluid IL-6 concentration and the association with both acute and chronic histologic chorioamnionitis.
| What is the significance of an elevation in the concentrations of amniotic fluid IL-6 and CXCL10?
Thirty-five percent (59/168) of patients in this study had elevated amniotic fluid concentrations of both IL-6 and CXCL10. All of them had spontaneous preterm delivery <37 weeks and <34 weeks of gestation, respectively, suggesting a severe inflammatory process associated with preterm delivery. Moreover, patients with an elevation in both amniotic fluid IL-6 and CXCL10 concentrations had a significantly higher frequency of spontaneous preterm delivery within 48 hours of amniocentesis than those with an isolated elevation in amniotic fluid CXCL10 concentration (Table 2) . Indeed, a systemic fetal inflammatory response (defined as the presence of funisitis or chorionic vasculitis) 197 was detected in 54.2% (32/59) of patients with an elevation in both amniotic fluid CXCL10 and IL-6 concentrations, but in only 34.6% (9/26) and 20% (6/30) of patients with an isolated elevation in amniotic fluid IL-6 or CXCL10 concentration, respectively ( Table 2 ). One interpretation proposes that patients with a combination of increased amniotic fluid IL-6 and CXCL10
concentrations had a more severe form of intra-amniotic inflammation than those with an isolated elevation in either CXCL10 or IL-6 concentration, in whom the clinical course leading to preterm delivery may be more indolent in nature. This could explain the trend toward a more frequent involvement of the fetus in patients with an elevation in both amniotic fluid CXCL10 and IL-6 concentrations.
CXCL10 has been implicated in the pathophysiology of sepsis by recruiting neutrophils, macrophages, and T cells. 291, 292 Previous studies demonstrated that there is an upregulation of CXCL10 leading to subsequent activation of its receptor (CXCR3) during infection and inflammation. 293, 294 In an experimental model of septic shock induced by cecal ligation and puncture, it has been shown that plasma and peritoneal fluid CXCL10 concentrations increase. 295 Additionally, CXCL10 knockout mice and wild-type mice treated with anti-CXCL10
IgG antibody had less cytokine production and increased survival. 296 Similar observations were found for the role of CXCR3 during sepsis; it regulates NK-and T-cell trafficking. Moreover, in a septic shock model for mice, the blockade of CXCR3 decreases systemic inflammation and improves survival. 296, 297 CXCL10 and CXCR3 also play a role in human sepsis, and plasma CXCL10 is a predictor of septic shock. [298] [299] [300] Collectively, these data suggest that CXCL10 is an inflammatory mediator involved in the response to microorganisms and bacterial products; therefore, some cases of advanced infections could have elevated concentrations of both IL-6 and CXCL10. An elevated amniotic fluid concentration of CXCL10 would be more meaningful to identify the patient at risk of chronic inflammatory lesions of the placenta if the amniotic fluid concentration of IL-6 is not elevated.
| Strengths and limitations
The major strengths of this study are as follows: pathologists were blinded to the obstetrical diagnoses and outcomes; standardized protocols were utilized for placental examinations; and the consideration of isolated rather than any increase in the concentration of either 
| CONCLUSION
An isolated elevation in amniotic fluid CXCL10 concentration (without a concomitant elevation in IL-6 concentration) is associated with the delivery of a placenta with histologic chronic chorioamnionitis or lesions consistent with maternal anti-fetal rejection, whereas an isolated increase in amniotic fluid IL-6 concentration is associated with the delivery of a placenta with acute histologic chorioamnionitis.
